FDA approves Novavax’s updated COVID vaccine targeting JN.1 strain
The U.S. Food and Drug Administration on Friday granted emergency approval for an updated version of the Novavax COVID vaccine. The updated vaccine is authorised for use in individuals 12 years of age and older and will target the JN.1 strain of the virus.
BELIEBTE BEITRÄGE
UK sets new climate target for 2035
November 13, 2024
Children go back to school after Valencia floods
November 13, 2024
Researchers document huge decline in African elephants
November 13, 2024
Mission: Impossible 8 title revealed
November 13, 2024
LIVEÜBERTRAGUNG